Drugmaker Sues Credit Suisse Over Risky Investments

Swiss drugmaker Roche Holding has sued Credit Suisse over risky investments sold by two former directors charged with fraud.

  • 20 Oct 2009
Swiss drugmaker Roche Holding has sued Credit Suisse over risky investments sold by two former directors charged with fraud. Filed in U.S. District Court for the Southern District of New York, the lawsuit alleges that the bank fraudulently invested more than $545 million of Roche's cash in “collateralized ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 4,755 19 11.75
2 Citi 4,288 14 10.60
3 Rabobank 2,633 4 6.51
4 Goldman Sachs 2,615 4 6.46
5 Barclays 2,603 8 6.43

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 83,931.01 244 12.94%
2 Bank of America Merrill Lynch 71,587.85 220 11.03%
3 Wells Fargo Securities 64,351.96 203 9.92%
4 JPMorgan 46,391.25 147 7.15%
5 Credit Suisse 37,323.31 115 5.75%